WDS:NYSEWoodside Energy Group Limited Analysis
Data as of 2026-06-14 - not real-time
$23.07
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Woodside Energy Group Ltd is trading at $23.07, comfortably above its 20‑day ($22.26) and 50‑day ($22.81) SMAs and well above the 200‑day SMA ($18.78), signaling a short‑term bullish bias. The MACD line sits above its signal line, the histogram is positive, and the RSI at 57.6 suggests room for further upside without being overbought; volume is increasing while the 30‑day volatility is high at 34.8%, and beta is essentially neutral at –0.04, indicating limited market‑wide risk.
Fundamentally, WDS trades at a forward‑looking PE of 16.2 versus an industry average of 21.5, and the DCF‑derived fair value of $30.95 implies a substantial discount. The dividend yield of 4.85% is attractive but the payout ratio of 74.6% coupled with negative free cash flow raises sustainability concerns. Recent material news highlights a bullish analyst thesis projecting a 55% upside to $33.73 by 2030 and reports that Exxon is evaluating a potential bid, both of which could act as catalysts for price appreciation.
Fundamentally, WDS trades at a forward‑looking PE of 16.2 versus an industry average of 21.5, and the DCF‑derived fair value of $30.95 implies a substantial discount. The dividend yield of 4.85% is attractive but the payout ratio of 74.6% coupled with negative free cash flow raises sustainability concerns. Recent material news highlights a bullish analyst thesis projecting a 55% upside to $33.73 by 2030 and reports that Exxon is evaluating a potential bid, both of which could act as catalysts for price appreciation.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above key moving averages and bullish MACD
- Increasing volume and supportive technical momentum
- Potential short‑term catalyst from Exxon bid rumors
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation upside versus DCF fair value
- High dividend yield relative to peers
- Analyst projections of 55% price appreciation by 2030
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Exposure to energy transition and regulatory headwinds
- Elevated debt levels and negative free cash flow
- Sustainable dividend concerns despite attractive yield
Key Metrics & Analysis
Financial Health
Revenue Growth-11.10%
Profit Margin20.93%
P/E Ratio16.2
ROE7.20%
ROA2.60%
Debt/Equity34.44
P/B Ratio1.2
Op. Cash Flow$7.2B
Free Cash Flow$-314375008
Industry P/E21.5
Technical Analysis
TrendNeutral
RSI57.6
Support$21.33
Resistance$24.71
MA 20$22.26
MA 50$22.81
MA 200$18.78
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$30.95
GradeUndervalued
TypeBlend
Dividend Yield4.85%
Risk Assessment
Beta-0.04
Volatility34.83%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.